Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease - Kocyigit, Ismail; Ozturk, Fahir; Eroglu, Eray; Karaca, Zuleyha; Kaynar, Ahmet Safa; Cetin, Mustafa; Tokgoz, Bulent; Sipahioglu, Murat Hayri; Bayramov, Ruslan; Sen, Ahmet; Oymak, Oktay; Ecder, Tevfik; et al. (Clinical and experimental nephrology, 2019)
Keywords: Adult; Biochemical markers; Biomarkers - blood; Body weight; Case-Control Studies; Cholesterol; Clinical Medicine; Diabetes; Diabetes mellitus; Disease Progression; Energy Metabolism; Epidermal growth factor receptors; Female; Genetic Predisposition to Disease; Homeostasis; Humans; Hypertension - diagnosis; Hypertension - epidemiology; IL-1β; Inflammation Mediators - blood; Insulin; Interleukin 6; Kidney diseases; Klinisk medicin; Male; Medical and Health Sciences; Medicin och hälsovetenskap; Medicine; Medicine & Public Health; Metabolic syndrome; Metabolic Syndrome - blood; Metabolic Syndrome - diagnosis; Metabolic Syndrome - epidemiology; Metabolic Syndrome - genetics; Metabolism; Middle Aged; Multivariate analysis; Mutation; Nephrology; Obesity; Original Article; Overweight; Phenotype; Phenotypes; Polycystic kidney; Polycystic Kidney, Autosomal Dominant - diagnosis; Polycystic Kidney, Autosomal Dominant - epidemiology; Polycystic Kidney, Autosomal Dominant - genetics; Prevalence; Renal Insufficiency, Chronic - diagnosis; Renal Insufficiency, Chronic - epidemiology; Renal Insufficiency, Chronic - genetics; Risk Factors; Time Factors; TRPP Cation Channels - genetics; Tumor necrosis factor-α; Turkey; Urology; Turkey; Obesity; PKD1 mutation; Metabolic syndrome; Renal progression; Polycystic kidney disease